Up at 5AM: The 5AM Solutions Blog

Download the Map of Biomedicine - Ebook Edition

Posted on Thu, Apr 23, 2015 @ 02:17 PM

It’s finally here: the Map of Biomedicine ebook!

Last year, 5AM’s Chief Science Officer Will FitzHugh started to make notes about the vast -- and expanding -- field for which we develop software: biomedicine. Originally, his purpose was keeping all of the players straight so that he and 5AM’s software development teams could have a big-picture view of the context that our clients work in, as well as details like the regulatory processes and technological shifts that impact human health.

Read More

Tags: biomedicine, map of biomedicine, diagnostic test development

A $250 Genetic Test Might Revolutionize Breast Cancer Diagnostics

Posted on Tue, Apr 21, 2015 @ 03:00 PM

The New York Times reported today that Color Genomics, a Silicon Valley startup has raised $115 million to make a $249 genetic test a reality. The test identifies faulty BRCA, as well as more than a dozen other cancer-related genes. BRCA1 and BRCA2 mutations are responsible for increasing women’s risks for developing certain breast and ovarian cancers. Filmmaker and actress Angelina Jolie has made headlines over the past few years for her decisions to undergo a preventive mastectomy, and more recently, a preventive oophorectomy in response to her own gene-related disease risks.

Read More

Tags: cancer, biomedicine, 23andMe, diagnostic test development, diagnostics, BRCA

Map of Biomedicine: Premarket Approval for Diagnostic Products

Posted on Thu, Jul 31, 2014 @ 12:00 PM

In the last few Map of Biomedicine blog posts I’ve talked about several different ways that diagnostic products can get to market. Laboratory-developed Tests (LDTs) and tests that get 510(k) approval (for tests that are similar to existing tests) are two ways.

Read More

Tags: map of biomedicine, diagnostic test development, 510(K), LDT, PMA, Premarket Approval

Map of Biomedicine: Getting Diagnostic Products to Market

Posted on Thu, Jul 10, 2014 @ 12:00 PM

In my last post, I talked about the laboratory-developed tests (LDT), or “home brews.” LDTs are run in individual labs whose operations are regulated under Clinical Laboratory Improvement Amendments (CLIA). The home brews, however, are essentially unregulated, except in the sense that physicians and hospitals won’t recommend tests that aren’t good for their patients.

Read More

Tags: map of biomedicine, diagnostic test development, 510(K), LDT, PMA

Diagnostic Test Development on the Map of Biomedicine

Posted on Thu, Jun 26, 2014 @ 06:39 PM

As I said in my introductory post to this series on the Map of Biomedicine, there’s incredible value in being to able to understand how things operate at a high level and also be able to drill down and see details. At the end of that post I showed a picture of the Map of Biomedicine that I’ve been working on. We’ll get back to talking about the overall map later, but for now I want to talk about some parts of the map in more detail. And just to answer one question up front: I’m sure this map will change. I’m guessing that in the process of writing these blog posts and fielding questions and comments, I’ll identify gaps and adjustments that will make the map more complete.

Read More

Tags: map of biomedicine, diagnostic test development, diagnostics, BRCA

GET OUR BLOG IN YOUR INBOX

Diagnostic Tests on the Map of Biomedicine

MoBsmCover

Download the ebook based on our popular blog series. This free, 50+ page edition features updated, expanded posts and redesigned, easier-to-read maps. 

FREE Biobanking Ebook

Biobanking Free Ebook
Get this 29 page PDF document on how data science can be used to advance biorepositories.

 Free NGS Whitepaper

NGS White Paper for Molecular Diagnostics

Learn about the applications, opportunities and challenges in this updated free white paper. 

Recent Posts